Diagnosis Of Liver Cancer Golgi Transmembrane Glycopro(GP73) Test Kit Tumor Maker Assay For Clinical In Vitro Diagnostic

Diagnosis of liver cancer Golgi transmembrane glycopro(GP73) test kit Tumor Maker Assay for Clinical In Vitro Diagnostic

CLIA Reagents of Tumor Maker(GP73)

^{Golgi protein 73 (GP73) exists on the Golgi apparatus and is a transmembrane glycoprotein. Under normal physiological conditions, GP73 is hardly expressed in human hepatocytes, but at low levels in bile duct epithelial cells, bronchial ciliated columnar epithelial cells, etc. Levels continue to express. GP73 is a kind of tumor marker and can be used for the diagnosis of liver cancer, but the high level of GP73 does not mean that you must have liver cancer.}

^{Abnormally expressed GP73 can be seen in hepatocytes after canceration, resulting in an increase in the detection value of GP73. However, GP73 is only one of the markers of liver cancer, and its elevated value cannot be used as the basis for the diagnosis of liver cancer. It needs to be combined with the detection of other tumor markers, such as alpha-fetoprotein, serum fucosidase, etc., as well as liver biopsy. nature of the disease.}

^{In other pathological conditions, such as viral and non-viral acute and chronic hepatobiliary diseases, the mRNA transcription and protein expression levels of GP73 will also increase significantly, which is significantly higher than normal, resulting in the increase of GP73}

^{Golgi transmembrane glycoprotein 73 (GP73) is an ideal serum marker for early diagnosis of liver cancer and evaluation of postoperative recurrence. Its sensitivity and specificity are much higher than that of alpha-fetoprotein (AFP), which was introduced 40 years ago. The detection will greatly improve the diagnosis and treatment of liver cancer.}